US Bans Canadian Alcohol, Motorcycles as Trade War Escalates 
Enflame Shares Surge 200% in Shanghai AI Chip Debut 
China Buys 1 Million Tons of U.S. Soybeans Ahead of Xi Visit 
Asian Stocks Fall as Oil Tops $100, Yields Rise 
German Inflation Accelerates to 2.9% in August 
BOJ Set to Raise Rates to 1.25% as Inflation Risks Build 
UK Economy Grows 0.4% in July, Beating Forecasts 
Asian Stocks Slide as Oil Surge Fuels Rate Hike Fears 
Iraq Seeks 6 Million Bpd OPEC+ Oil Quota 
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback 
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico 
Oil Prices Hold Near Highs as U.S.-Iran Conflict Escalates 
France Keeps Top Health Alert as Officials Brace for Another Heatwave 
US Judge Dismisses Imran Ahmed Deportation Lawsuit 
CK Hutchison Seeks $1.5 Billion From Panama Over Canal Ports 
UK Food Inflation Forecast to Hit 6.4% by Mid-2027 
Add as a preferred source on Google
The US Food and Drug Administration (FDA) is planning to regulate the use of the cannabis compound CBD in food and supplements after weighing the evidence on the compound's safety.
The FDA will decide whether regulating legal cannabis will require new agency rules or new legislation from Congress.
Cannabis products, excluding Epidiolex, are illegal at the federal level in the US, although some states allow their use.
According to Patrick Cournoyer, who heads the FDA office developing the agency's cannabis strategy, the FDA will ascertain if CBD can be safely eaten every day for a long period or during pregnancy amid concerns about future fertility.
.
